XENE Stock Summary and Trading Ideas (Xenon Pharmaceuticals - Common Shares | NASDAQ:XENE)

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol XENE.

As of February 24, 2026, XENE stock price climbed to $44.79 with 860,919 million shares trading.

XENE has a beta of 0.85, meaning it tends to be less sensitive to market movements. XENE has a correlation of 0.12 to the broad based SPY ETF.

XENE has a market cap of $3.45 billion. This is considered a Mid Cap stock.

In the last 3 years, XENE traded as high as $50.99 and as low as $26.74.

The top ETF exchange traded funds that XENE belongs to (by Net Assets): IWM, IWO, IBB, VTWO, SPDW.

XENE has underperformed the market in the last year with a return of +12.7%, while SPY returned +15.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XENE shares. However, XENE has outperformed the market in the last 3 month and 2 week periods, returning +8.8% and +5.6%, while SPY returned +4.6% and -1.0%, respectively. This indicates XENE has been having a stronger performance recently.

XENE support price is $41.77 and resistance is $43.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XENE shares will trade within this expected range on the day.